NGS testing explained for physicians: Uses in oncology, liquid biopsies, and evolving reimbursement, with insights…
Sermo Physician Resources
Emerging Therapies
Journavx FDA approval: non-opioid pain management in 2026
Journavx (suzetrigine) is the first new pain drug class in 20 years. Explore trial results,…
The Lyme epidemic: is your practice ready for the global spread?
Analyze the current Lyme disease epidemic, focusing on tick habitat expansion, new Phase 3 vaccine…
Balancing efficiency with clinical safety through outpatient care
On Sermo, physicians analyze the shift to outpatient care, sharing concerns about safety oversight, complication…
How AI is reshaping drug development in 2026: discovery to delivery
On Sermo, physicians explore how AI is transforming drug development, from rational design to predictive…
Digital twins in healthcare: simulating health for better care decisions
Analysis of Digital Twins (DTs) in clinical care, predicting treatment outcomes, top physician concerns, and…
Diagnostic technology tools for physicians in 2026
Explore the latest diagnostic technologies and learn how they're revolutionizing patient care. Join the conversation…
Mobile healthcare technology tools to enhance patient care
Explore the top mobile healthcare technology trends for 2025 and beyond. Discover the latest innovations…
The rise of psilocybin therapy: A new horizon in mental healthcare
Explore the potential of psilocybin therapy for treatment-resistant depression and other conditions. Learn more about…
The future of pain management: a new approach to care
Learn how doctors are managing pain with non-opioid techniques, addressing disparities, and restoring patient trust.…
GLP-1s: Who’s in control, doctors or PBMs?
Sermo’s new report explores the tension between GLP-1 efficacy and access. Discover how PBMs and…
The rise of AI: redefining medicine with intelligent tools
Explore how AI is revolutionizing diagnostics, patient care, and clinical workflows. Join the conversation with…